Opinion|Videos|December 3, 2024
Addressing Challenges in Accessing Traditional STI Screening Options
Author(s)Kameelah Phillips, MD, FACOG, NCMP
The panelist discusses how asymptomatic sexually transmitted infections (STIs) can silently impact overall health, emphasizing the importance of comprehensive screening and education, particularly for less known STIs like trichomoniasis and Mycoplasma genitalium, while exploring how newer testing methods like nucleic acid amplification testing (NAAT) can address challenges in traditional screening access and improve patient care.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- In what ways can asymptomatic STIs impact overall health, and why is screening important?
- How can health care providers effectively raise awareness about less commonly known STIs like trichomoniasis and Mycoplasma genitalium?
- What challenges do patients face when accessing traditional STI screenings testing, and how can these be addressed?
- How does the use of newer screening methods like NAAT impact patient access to necessary screenings?
Advertisement
Related to this article
Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
A new study finds that low birth volume and unprofitability were strongly associated with both obstetric unit and full hospital closures between 2010 and 2023.
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.
Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.
A global consensus published in The Lancet has officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a change with broad implications for diagnosis, care, and cardiometabolic screening.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care
2
IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4
3
Preeclampsia Foundation launches postpartum recovery videos for HDP
4
Top headlines in women's health from September 2026
5